A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

Recent scientific discoveries are challenging traditional views of Parkinson’s disease, suggesting that this neurological condition might actually begin in an unexpected place, the digestive system.

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

"In Parkinson's disease you need a whole team ... serotonin, dopamine, and acetylcholine. Those neurological changes don’t, at first, lead to the motor symptoms that are commonly associated ...

This is not the kind of honor I ever anticipated on my life bingo card. But I never expected a Parkinson’s disease diagnosis, either. Or starting a foundation that bears my name, which has ...

Over an average follow-up period of 14.24 years, 810 participants were subsequently diagnosed with Parkinson's disease. The analysis revealed a 57% increased risk of Parkinson's for every 10 ...

the finding that acetylcholine-receptor antagonists have an antiproliferative effect on neural stem cells has important implications for the understanding and treatment of Alzheimer's disease.

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents ... Alzheimer's and Parkinson's.